A fragment of SPARC reflecting increased collagen affinity shows pathological relevance in lung cancer – implications of a new collagen chaperone function of SPARC

References

• Sangaletti S, Tripodo C, Cappetti B, Casalini P, Chiodoni C, Piconese S, Santangelo A, Parenza M, Arioli I, Miotti S, et al. 2011. SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage. Am J Pathol. 179:3000–3010. doi:10.1016/j.ajpath.2011.08.027.
   PubMed Web of Science ®Google Scholar
• Strandjord TP, Madtes DK, Weiss DJ, Sage EH. Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis. Am J Physiol. 277;1999:L628–35.
   PubMed Web of Science ®Google Scholar
• Wang J-C, Lai S, Guo X, Zhang X, De Crombrugghe B, Sonnylal S, Arnett FC, Zhou X. 2010. Attenuation of fibrosis in vitro and in vivo with SPARC siRNA. Arthritis Res Ther. 12:1–9. doi:10.1186/ar2973.
   Web of Science ®Google Scholar
• Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, et al. 1996. SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int. 50:1978–1989. doi:10.1038/ki.1996.520.
   PubMed Web of Science ®Google Scholar
• Camino AM, Atorrasagasti C, Maccio D, Prada F, Salvatierra E, Rizzo M, Alaniz L, Aquino JB, Podhajcer OL, Silva M, et al. 2008. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats. J Gene Med. 10:993–1004. doi:10.1002/jgm.v10:9.
   PubMed Web of Science ®Google Scholar
• Neuzillet C, Tijeras-Raballand A, Cros J, Faivre S, Hammel P, Raymond E. Stromal expression of SPARC in pancreatic adenocarcinoma. Cancer and Metastasis Rev. 2013;32:585–602. doi:10.1007/s10555-012-9414-4.
   PubMed Web of Science ®Google Scholar
• Wong SLI, Sukkar MB. 2017. The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease. Br J Pharmacol. 174:3–14. doi:10.1111/bph.13653.
   PubMed Web of Science ®Google Scholar
• Frizell E, Liu SL, Abraham A, Ozaki I, Eghbali M, Sage EH, Zern MA. Expression of SPARC in normal and fibrotic livers. Hepatology. 1995;21:847–854.
   PubMed Web of Science ®Google Scholar
• Kuhn C, Mason RJ. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol. 147;1995:1759–1769.
   PubMed Web of Science ®Google Scholar
• Lane TF, Sage EH. 1994. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8:163–173. doi:10.1096/fasebj.8.2.8119487.
   PubMed Web of Science ®Google Scholar
• Bradshaw AD. 2009. The role of SPARC in extracellular matrix assembly. J Cell Commun Signal. 3:239–246. doi:10.1007/s12079-009-0062-6.
   PubMed Web of Science ®Google Scholar
• Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol. 19;2000:569–580.
   PubMed Web of Science ®Google Scholar
• Chiodoni C, Colombo MP, Sangaletti S. 2010. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer and Metastasis Rev. 29:295–307. doi:10.1007/s10555-010-9221-8.
   PubMed Web of Science ®Google Scholar
• Yan Q, Sage EH. 1999. SPARC, a Matricellular Glycoprotein with Important Biological Functions. J Histochem Cytochem. 47:1495–1505. doi:10.1177/002215549904701201.
   PubMed Web of Science ®Google Scholar
• Ribeiro N, Sousa SR, Brekken RA, Monteiro FJ. 2014. Role of sparc in bone remodeling and cancer-related bone metastasis. J Cell Biochem. 115:17–26. doi:10.1002/jcb.v115.1.
   PubMed Web of Science ®Google Scholar
• Tai IT, Tang MJ. 2008. SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat. 11:231–246. doi:10.1016/j.drup.2008.08.005.
   PubMed Web of Science ®Google Scholar
• Chlenski A, Cohn SL. 2010. Modulation of matrix remodeling by SPARC in neoplastic progression. Semin Cell Dev Biol. 21:55–65. doi:10.1016/j.semcdb.2009.11.018.
   PubMed Web of Science ®Google Scholar
• Rosset EM, Bradshaw AD. 2016. SPARC/osteonectin in mineralized tissue. Matrix Biol. 52–54:78–87. doi:10.1016/j.matbio.2016.02.001.
   PubMed Web of Science ®Google Scholar
• Bradshaw AD, Baicu CF, Rentz TJ, Van Laer AO, Boggs J, Lacy JM, Zile MR. 2009. Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing. Circulation. 119:269–280. doi:10.1161/CIRCULATIONAHA.108.773424.
   PubMed Web of Science ®Google Scholar
• Bradshaw AD, Puolakkainen P, Wight TN, Helene Sage E, Dasgupta J, Davidson JM. 2003. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol. 120:949–955. doi:10.1046/j.1523-1747.2003.12241.x.
   PubMed Web of Science ®Google Scholar
• Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. 2000. Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest. 105:915–923. doi:10.1172/JCI7039.
   PubMed Web of Science ®Google Scholar
• Rentz TJ, Poobalarahi F, Bornstein P, Sage EH, Bradshaw AD. 2007. SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. J Biol Chem. 282:22062–22071. doi:10.1074/jbc.M700167200.
   PubMed Web of Science ®Google Scholar
• Trombetta-eSilva J. 2012. The Function of SPARC as a Mediator of Fibrosis. Open Rheumatol J. 6:146–155. doi:10.2174/1874312901206010146.
   PubMedGoogle Scholar
• Trombetta JM, Bradshaw AD, Johnson RH. 2010. SPARC/Osteonectin Functions to Maintain Homeostasis of the Collagenous Extracellular Matrix in the Periodontal Ligament. J Histochem Cytochem. 58:871–879. doi:10.1369/jhc.2009.954354.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Göhring W, Mann K, Maurer P, Hohenester E, Knäuper V, Murphy G, Timpl R. 1997. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem. 272:9237–9243. doi:10.1074/jbc.272.14.9237.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Miosge N, Timpl R. 1999. Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin, SPARC) which are correlated to a higher affinity binding to collagens. Matrix Biol. 18:499–508. doi:10.1016/S0945-053X(99)00041-4.
   PubMed Web of Science ®Google Scholar
• Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res. 6;2000:4823–4830.
   PubMed Web of Science ®Google Scholar
• Orlichenko LS, Radisky DC. 2008. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin Exp Metastasis. 25:593–600. doi:10.1007/s10585-008-9143-9.
   PubMed Web of Science ®Google Scholar
• Maurer P, Göhring W, Sasaki T, Mann K, Timpl R, Nischt R. Recombinant and tissue-derived mouse BM-40 bind to several collagen types and have increased affinities after proteolytic activation. Cell Mol Life Sci. 1997;53:478–484.
   PubMed Web of Science ®Google Scholar
• Gilles C, Bassuk JA, Pulyaeva H, Sage EH, Foidart JM, Thompson EW. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res. 1998;58:5529–5536.
   PubMed Web of Science ®Google Scholar
• Jacob K, Webber M, Benayahu D, Kleinman HK. Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone. Cancer Res. 59;1999:4453–4457.
   PubMed Web of Science ®Google Scholar
• Tremble PM, Lane TF, Sage EH, Werb Z. 1993. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinases in fibroblasts through a novel extracellular matrix-dependent pathway. J Cell Biol. 121:1433–1444. doi:10.1083/jcb.121.6.1433.
   PubMed Web of Science ®Google Scholar
• Emerson RO, Sage EH, Ghosh JG, Clark JI. 2006. Chaperone-like activity revealed in the matricellular protein SPARC. J Cell Biochem. 98:701–705. doi:10.1002/(ISSN)1097-4644.
   PubMed Web of Science ®Google Scholar
• Combet C, Blanchet C, Geourjon C, Deléage G. 2000. NPS@: network protein sequence analysis. Trends Biochem Sci. 25:147–150. doi:10.1016/S0968-0004(99)01540-6.
   PubMed Web of Science ®Google Scholar
• Gefter ML, Margulies DH, Scharff MD. 1977. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet. 3:231–236. doi:10.1007/BF01551818.
   PubMedGoogle Scholar
• Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM, et al. 2010. A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem. 43:899–904. doi:10.1016/j.clinbiochem.2010.03.012.
   PubMed Web of Science ®Google Scholar
• Leeming D, He Y, Veidal SS, Nguyen Q, Larsen DV, Koizumi M, Segovia-Silvestre T, Zhang C, Zheng Q, Sun S, et al. 2011. A novel marker for assessment of liver matrix remodeling: an enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M). Biomarkers. 16:616–628. doi:10.3109/1354750X.2011.620628.
   PubMed Web of Science ®Google Scholar